Description
An active metabolite of lidocaine; formed via N-deethylation of lidocaine by hepatic CYP3A4; topical administration reduces thrombus formation in a hamster model of laser-induced microvascular injury at 2% v/v; plasma levels following lidocaine administration have been used to monitor declining liver function in patients with cirrhosis ,
Formal name: N-(2,6-dimethylphenyl)-2-(ethylamino)-acetamide, monohydrochloride
Synonyms: Monoethylglycinexylidide|Norlidocaine
Molecular weight: 242.7
CAS: 7729-94-4
Purity: ≥95%
Formulation: A solid
Product Type|Biochemicals|Xenobiotic Metabolites||Research Area|Cardiovascular System|Blood|Thrombosis||Research Area|Cardiovascular System|Vasculature||Research Area|Toxicology|Drug Metabolism|Cytochrome P450